Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Best 6 Advances in Cataract Surgery
Cataract surgery has undergone remarkable advancements, leading to significant improvements in patient outcomes and revolutionizing the field of ophthalmology. From advanced surgical techniques to innovative intraocular lens (IOL) options, this article explores the top six breakthroughs in cataract surgery that…
Iris Prolapse: Causes, Symptoms and Treatment
Iris prolapse is a condition wherein the iris, the colored part of the eye responsible for controlling the amount of light entering the eye, protrudes out through a surgical wound or a traumatic wound in the cornea or sclera. This…
10 Facts About Ophthalmologists and Their Work
Ophthalmologists, often referred to as eye doctors, are healthcare professionals who specialize in the diagnosis, treatment, and management of eye diseases and disorders. While we may visit them for routine eye exams or specific vision concerns, the world of ophthalmology…
New FDA Warning: Hearing Impairment Risks in TEPEZZA
The US Food and Drug Administration (FDA) has taken action to update the warning label on Horizon Pharmaceutical’s TEPEZZA, a drug used to treat thyroid eye disease (TED), to include the risk of hearing impairment or loss. The recent addition…
Edenlux’s Otus Personal EYE-Trainer | OBN
The Otus personal eye-trainer, developed by Edenlux, has launched a campaign through Indiegogo. The device uses training called Vision Therapy to relieve the stress of the eyes. Vision Therapy is an exercise that repeats the contraction and relaxation of the…
FDA Approves Vuity for Twice-Daily Dosing in Presbyopia
AbbVie, the parent company of Allergan, has announced that the FDA has granted approval for the use of Vuity (pilocarpine HCl ophthalmic solution) 1.25% twice a day in adults suffering from presbyopia. The second dose, consisting of an additional drop…
FDA Accepts Application for Genentech’s Vabysmo for RVO
Genentech announced that the FDA has accepted the company’s supplemental biologics license application (sBLA) for Vabysmo (faricimab-svoa) for the treatment of macular edema following retinal vein occlusion (RVO). The sBLA is based on data from the phase 3 BALATON and…
Are Eye Pressure Fluctuation Normal or Cause for Concern?
Intraocular pressure (IOP) is a critical measurement in eye health, often associated with eye conditions like glaucoma. This pressure is the force exerted by the aqueous humor, the fluid inside the eye, on the ocular structures. Traditionally, eye pressure has…
Norlase Raises $11M in Funding for ECHO Pattern Laser
Norlase, a leading laser technology company, has recently secured its largest investment round to date, raising $11 million. This significant funding will empower Norlase to expedite the production ramp-up of its cutting-edge ECHO pattern laser, which recently received FDA clearance…
Stuart Therapeutics and Glaukos’ Exclusive License Deal
Stuart Therapeutics announced that it has signed an exclusive agreement with Glaukos Corporation. In this agreement, Glaukos gains exclusive global rights to develop and market Stuart’s proprietary drug candidate, ST-113, which focuses on neuroprotection in the context of glaucoma. ST-113,…